{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:20:02Z","timestamp":1786447202493,"version":"build-2736575974"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:00:00Z","timestamp":1755648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Foundation of Health Commission of Hubei Province","award":["WJ2023M161"],"award-info":[{"award-number":["WJ2023M161"]}]},{"name":"the Open Research Fund Program of the State Key Laboratory of Virology of China at Wuhan University","award":["2023KF001"],"award-info":[{"award-number":["2023KF001"]}]},{"name":"the Innovative Research Program for Graduate of Hubei University of Medicine","award":["YC2024017"],"award-info":[{"award-number":["YC2024017"]}]},{"name":"the Hubei Province Natural Science Foundation Joint Fund Project","award":["202500613"],"award-info":[{"award-number":["202500613"]}]},{"name":"the Innovative Research Program of Xiangyang No.1 People\u2019s Hospital","award":["XYY2025LJ05"],"award-info":[{"award-number":["XYY2025LJ05"]}]},{"name":"the Hubei Science and Technology Project","award":["2023BCB140"],"award-info":[{"award-number":["2023BCB140"]}]},{"name":"the Key Project of Xiangyang Science and Technology Bureau","award":["2022YL35A"],"award-info":[{"award-number":["2022YL35A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/s12941-025-00812-9","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T11:14:25Z","timestamp":1755688465000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification and preclinical efficacy evaluation of two lytic bacteriophages targeting highly virulent and multidrug-resistant Klebsiella pneumoniae"],"prefix":"10.1186","volume":"24","author":[{"given":"Ai","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianbao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinquan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caili","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,20]]},"reference":[{"issue":"3","key":"812_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1128\/MMBR.00078-15","volume":"80","author":"MK Paczosa","year":"2016","unstructured":"Paczosa MK, Mecsas J. Klebsiella pneumoniae: going on the offense with a strong defense. Microbiol Mol Biol Rev. 2016;80(3):629\u201361.","journal-title":"Microbiol Mol Biol Rev"},{"key":"812_CR2","doi-asserted-by":"crossref","unstructured":"Poerio N, Olimpieri T, Henrici De Angelis L, De Santis F, Thaller MC, D\u2019Andrea MM et al. Fighting MDR-Klebsiella pneumoniae infections by a combined Host- and Pathogen-Directed therapeutic approach. Front Immunol. 2022.13.","DOI":"10.3389\/fimmu.2022.835417"},{"key":"812_CR3","doi-asserted-by":"crossref","unstructured":"Holt KE, Wertheim H, Zadoks RN, Baker S, Whitehouse CA, Dance D et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proceedings of the National Academy of Sciences. 2015.112(27).","DOI":"10.1073\/pnas.1501049112"},{"issue":"9","key":"812_CR4","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","volume":"13","author":"LS Munoz-Price","year":"2013","unstructured":"Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13(9):785\u201396.","journal-title":"Lancet Infect Dis"},{"key":"812_CR5","doi-asserted-by":"crossref","unstructured":"Abdelrahman F, Easwaran M, Daramola OI, Ragab S, Lynch S, Oduselu TJ et al. Phage-Encoded Endolysins Antibiot. 2021.10(2).","DOI":"10.3390\/antibiotics10020124"},{"issue":"7795","key":"812_CR6","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/s41586-020-2007-4","volume":"578","author":"B Al-Shayeb","year":"2020","unstructured":"Al-Shayeb B, Sachdeva R, Chen L-X, Ward F, Munk P, Devoto A, et al. Clades of huge phages from across earth\u2019s ecosystems. Nature. 2020;578(7795):425\u201331.","journal-title":"Nature"},{"key":"812_CR7","doi-asserted-by":"crossref","unstructured":"Lin DM, Koskella B, Lin HC. Phage therapy: an alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther. 2017.8(3).","DOI":"10.4292\/wjgpt.v8.i3.162"},{"key":"812_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/3510124","volume":"2017","author":"M Feldman","year":"2017","unstructured":"Feldman M, Shenderovich J, Lavy E, Friedman M, Steinberg D. A Sustained-Release membrane of Thiazolidinedione-8: effect on formation of a candida\/bacteria mixed biofilm on hydroxyapatite in a continuous flow model. Biomed Res Int. 2017;2017:1\u20139.","journal-title":"Biomed Res Int"},{"key":"812_CR9","doi-asserted-by":"crossref","unstructured":"Save J, Que YA, Entenza JM, Kolenda C, Laurent F, Resch G. Bacteriophages combined with subtherapeutic doses of Flucloxacillin act synergistically against Staphylococcus aureus experimental infective endocarditis. J Am Heart Association. 2022.11(3).","DOI":"10.1161\/JAHA.121.023080"},{"key":"812_CR10","doi-asserted-by":"crossref","unstructured":"Duerkop BA, Huo W, Bhardwaj P, Palmer KL, Hooper LV, Miller JF. Molecular basis for lytic bacteriophage resistance in enterococci. mBio. 2016.7(4).","DOI":"10.1128\/mBio.01304-16"},{"key":"812_CR11","doi-asserted-by":"crossref","unstructured":"Ichikawa M, Nakamoto N, Kredo-Russo S, Weinstock E, Weiner IN, Khabra E et al. Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis. Nat Commun. 2023.14(1).","DOI":"10.1038\/s41467-023-39029-9"},{"key":"812_CR12","doi-asserted-by":"crossref","unstructured":"Chan BK, Sistrom M, Wertz JE, Kortright KE, Narayan D, Turner PE. Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa. Sci Rep. 2016.6(1).","DOI":"10.1038\/srep26717"},{"issue":"15","key":"812_CR13","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1128\/JVI.00385-15","volume":"89","author":"DP Pires","year":"2015","unstructured":"Pires DP, Vilas Boas D, Sillankorva S, Azeredo J, Goff SP. Phage therapy: a step forward in the treatment of Pseudomonas aeruginosa infections. J Virol. 2015;89(15):7449\u201356.","journal-title":"J Virol"},{"key":"812_CR14","doi-asserted-by":"crossref","unstructured":"Bai J, Zhang F, Liang S, Chen Q, Wang W, Wang Y et al. Isolation and characterization of vB_kpnM_17\u2013\u200911, a novel phage efficient against Carbapenem-Resistant Klebsiella pneumoniae. Front Cell Infect Microbiol. 2022.12.","DOI":"10.3389\/fcimb.2022.897531"},{"issue":"1","key":"812_CR15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/phage.2022.0005","volume":"3","author":"CM Carmody","year":"2022","unstructured":"Carmody CM, Farquharson EL, Nugen SR. Enterobacteria phage SV76 host range and genomic characterization. Phage. 2022;3(1):59\u201363.","journal-title":"Phage"},{"key":"812_CR16","doi-asserted-by":"crossref","unstructured":"Wang J, Zhang M, Pei J, Yi W, Fan L, Wang C et al. Isolation and identification of a novel phage targeting clinical multidrug-resistant Corynebacterium striatum isolates. Front Cell Infect Microbiol. 2024.14.","DOI":"10.3389\/fcimb.2024.1361045"},{"issue":"5","key":"812_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1007\/s11262-022-01917-5","volume":"58","author":"F Li","year":"2022","unstructured":"Li F, Li L, Zhang Y, Bai S, Sun L, Guan J, et al. Isolation and characterization of the novel bacteriophage vB_SmaS_BUCT626 against Stenotrophomonas maltophilia. Virus Genes. 2022;58(5):458\u201366.","journal-title":"Virus Genes"},{"key":"812_CR18","doi-asserted-by":"crossref","unstructured":"Abedon ST. Phage therapy dosing: the problem(s) with multiplicity of infection (MOI). Bacteriophage. 2016.6(3).","DOI":"10.1080\/21597081.2016.1220348"},{"key":"812_CR19","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jgar.2024.03.007","volume":"37","author":"S Liu","year":"2024","unstructured":"Liu S, Xu H, Cao R, Yang Z, Li X. Isolation, identification, and biological characterization of phage vB_KpnM_KpVB3 targeting Carbapenem-Resistant Klebsiella pneumoniae ST11. J Global Antimicrob Resist. 2024;37:179\u201384.","journal-title":"J Global Antimicrob Resist"},{"issue":"9","key":"812_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1046\/j.1469-0691.2000.00142.x","volume":"6","author":"Determination of minimum inhibitory","year":"2000","unstructured":"Determination of minimum inhibitory. Concentrations (MICs) of antibacterial agents by agar Dilution. Clin Microbiol Infect. 2000;6(9):509\u201315.","journal-title":"Clin Microbiol Infect"},{"key":"812_CR21","doi-asserted-by":"crossref","unstructured":"Fang C, Dai X, Xiang L, Qiu Y, Yin M, Fu Y et al. Isolation and characterization of three novel lytic phages against K54 serotype carbapenem-resistant hypervirulent Klebsiella pneumoniae. Front Cell Infect Microbiol. 2023.13.","DOI":"10.3389\/fcimb.2023.1265011"},{"key":"812_CR22","doi-asserted-by":"crossref","unstructured":"Schuch R, Pelzek AJ, Nelson DC, Fischetti VA, Dozois CM. The plyb endolysin of bacteriophage vB_BanS_Bcp1 exhibits Broad-Spectrum bactericidal activity against Bacillus cereus sensu Lato isolates. Appl Environ Microbiol. 2019.85(9).","DOI":"10.1128\/AEM.00003-19"},{"key":"812_CR23","doi-asserted-by":"crossref","unstructured":"Oliveira VC, Macedo AP, Melo LDR, Santos SB, Hermann PRS, Silva-Lovato CH et al. Bacteriophage Cocktail-Mediated Inhibition of Pseudomonas aeruginosa biofilm on endotracheal tube surface. Antibiotics. 2021.10(1).","DOI":"10.3390\/antibiotics10010078"},{"key":"812_CR24","doi-asserted-by":"crossref","unstructured":"Assoni L, Couto AJM, Vieira B, Milani B, Lima AS, Converso TR et al. Animal models of Klebsiella pneumoniae mucosal infections. Front Microbiol. 2024.15.","DOI":"10.3389\/fmicb.2024.1367422"},{"key":"812_CR25","doi-asserted-by":"crossref","unstructured":"Cui X, Du B, Feng J, Feng Y, Fan Z, Chen J et al. A novel phage carrying capsule depolymerase effectively relieves pneumonia caused by multidrug-resistant Klebsiella aerogenes. J Biomed Sci. 2023.30(1).","DOI":"10.1186\/s12929-023-00946-y"},{"key":"812_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jgar.2019.09.018","volume":"21","author":"T Anand","year":"2020","unstructured":"Anand T, Virmani N, Kumar S, Mohanty AK, Pavulraj S, Bera BC, et al. Phage therapy for treatment of virulent Klebsiella pneumoniae infection in a mouse model. J Global Antimicrob Resist. 2020;21:34\u201341.","journal-title":"J Global Antimicrob Resist"},{"key":"812_CR27","doi-asserted-by":"crossref","unstructured":"Eskenazi A, Lood C, Wubbolts J, Hites M, Balarjishvili N, Leshkasheli L et al. Combination of pre-adapted bacteriophage therapy and antibiotics for treatment of fracture-related infection due to pandrug-resistant Klebsiella pneumoniae. Nat Commun. 2022.13(1).","DOI":"10.1038\/s41467-021-27656-z"},{"key":"812_CR28","doi-asserted-by":"crossref","unstructured":"Li P, Guo G, Zheng X, Xu S, Zhou Y, Qin X et al. Therapeutic efficacy of a K5-specific phage and depolymerase against Klebsiella pneumoniae in a mouse model of infection. Vet Res. 2024.55(1).","DOI":"10.1186\/s13567-024-01311-z"},{"key":"812_CR29","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.2147\/IDR.S326230","volume":"14","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Meng B, Wei X, Li Y, Wang X, Zheng Y, et al. Evaluation of phage therapy for pulmonary infection of mouse by liquid Aerosol-Exposure Pseudomonas aeruginosa. Infect Drug Resist. 2021;14:4457\u201369.","journal-title":"Infect Drug Resist"},{"key":"812_CR30","doi-asserted-by":"crossref","unstructured":"Wu J-W, Wang J-T, Lin T-L, Liu Y-Z, Wu L-T, Pan Y-J. Identification of three capsule depolymerases in a bacteriophage infecting Klebsiella pneumoniae capsular types K7, K20, and K27 and therapeutic application. J Biomed Sci. 2023.30(1).","DOI":"10.1186\/s12929-023-00928-0"},{"key":"812_CR31","doi-asserted-by":"crossref","unstructured":"Pustam A, Jayaraman J, Ramsubhag A. Characterization of Beta-Lactam resistance genes and virulence factors associated with Multidrug-Resistant Klebsiella pneumoniae isolated from patients at major hospitals in trinidad, West Indies. Curr Microbiol. 2022.79(9).","DOI":"10.1007\/s00284-022-02972-9"},{"key":"812_CR32","doi-asserted-by":"crossref","unstructured":"Li L, Li S, Wei X, Lu Z, Qin X, Li M. Infection with Carbapenem-resistant hypervirulent Klebsiella pneumoniae: clinical, virulence and molecular epidemiological characteristics. Antimicrob Resist Infect Control. 2023.12(1).","DOI":"10.1186\/s13756-023-01331-y"},{"issue":"4","key":"812_CR33","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1093\/femsre\/fuw007","volume":"40","author":"RF Maldonado","year":"2016","unstructured":"Maldonado RF, S\u00e1-Correia I, Valvano MA, Whitfield C. Lipopolysaccharide modification in Gram-negative bacteria during chronic infection. FEMS Microbiol Rev. 2016;40(4):480\u201393.","journal-title":"FEMS Microbiol Rev"},{"key":"812_CR34","doi-asserted-by":"crossref","unstructured":"Li L, Gao X, Li M, Liu Y, Ma J, Wang X et al. Relationship between biofilm formation and antibiotic resistance of Klebsiella pneumoniae and updates on antibiofilm therapeutic strategies. Front Cell Infect Microbiol. 2024.14.","DOI":"10.3389\/fcimb.2024.1324895"},{"issue":"5418","key":"812_CR35","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","volume":"284","author":"JW Costerton","year":"1999","unstructured":"Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: A common cause of persistent infections. Science. 1999;284(5418):1318\u201322.","journal-title":"Science"},{"issue":"5","key":"812_CR36","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.mib.2013.06.013","volume":"16","author":"C de la Fuente-N\u00fa\u00f1ez","year":"2013","unstructured":"de la Fuente-N\u00fa\u00f1ez C, Reffuveille F, Fern\u00e1ndez L, Hancock REW. Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies. Curr Opin Microbiol. 2013;16(5):580\u20139.","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"812_CR37","doi-asserted-by":"publisher","first-page":"a010306","DOI":"10.1101\/cshperspect.a010306","volume":"3","author":"M Kostakioti","year":"2013","unstructured":"Kostakioti M, Hadjifrangiskou M, Hultgren SJ. Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. Cold Spring Harbor Perspect Med. 2013;3(4):a010306\u2013a.","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"812_CR38","doi-asserted-by":"crossref","unstructured":"Latka A, Drulis-Kawa Z. Advantages and limitations of microtiter biofilm assays in the model of antibiofilm activity of Klebsiella phage KP34 and its depolymerase. Sci Rep. 2020.10(1).","DOI":"10.1038\/s41598-020-77198-5"},{"issue":"4","key":"812_CR39","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.micpath.2007.01.001","volume":"42","author":"HY Lau","year":"2007","unstructured":"Lau HY, Clegg S, Moore TA. Identification of Klebsiella pneumoniae genes uniquely expressed in a strain virulent using a murine model of bacterial pneumonia. Microb Pathog. 2007;42(4):148\u201355.","journal-title":"Microb Pathog"},{"key":"812_CR40","doi-asserted-by":"crossref","unstructured":"Ashworth EA, Wright RCT, Shears RK, Wong JKL, Hassan A, Hall JPJ et al. Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo. Nat Commun. 2024.15(1).","DOI":"10.1038\/s41467-024-45785-z"},{"issue":"10","key":"812_CR41","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1099\/vir.0.043562-0","volume":"93","author":"CK Mishra","year":"2012","unstructured":"Mishra CK, Choi TJ, Kang SC. Isolation and characterization of a bacteriophage F20 virulent to Enterobacter aerogenes. J Gen Virol. 2012;93(10):2310\u20134.","journal-title":"J Gen Virol"},{"key":"812_CR42","doi-asserted-by":"crossref","unstructured":"Li E, Wei X, Ma Y, Yin Z, Li H, Lin W et al. Isolation and characterization of a bacteriophage phiEap-2 infecting multidrug resistant Enterobacter aerogenes. Sci Rep. 2016.6(1).","DOI":"10.1038\/srep28338"},{"key":"812_CR43","doi-asserted-by":"crossref","unstructured":"Lewis R, Clooney AG, Stockdale SR, Buttimer C, Draper LA, Ross RP et al. Isolation of a novel Jumbo bacteriophage effective against Klebsiella aerogenes. Front Med. 2020.7.","DOI":"10.3389\/fmed.2020.00067"},{"issue":"7","key":"812_CR44","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1080\/21505594.2017.1317412","volume":"8","author":"JC Catal\u00e1n-N\u00e1jera","year":"2017","unstructured":"Catal\u00e1n-N\u00e1jera JC, Garza-Ramos U, Barrios-Camacho H. Hypervirulence and hypermucoviscosity: two different but ComplementaryKlebsiellaspp. phenotypes? Virulence. 2017;8(7):1111\u201323.","journal-title":"phenotypes? Virulence"},{"key":"812_CR45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.micpath.2017.03.034","volume":"107","author":"E Soto","year":"2017","unstructured":"Soto E, Dennis MM, Beierschmitt A, Francis S, Sithole F, Halliday-Simmons I, et al. Biofilm formation of hypermucoviscous and non-hypermucoviscous Klebsiella pneumoniae recovered from clinically affected African green monkey (Chlorocebus aethiops sabaeus). Microb Pathog. 2017;107:198\u2013201.","journal-title":"Microb Pathog"},{"key":"812_CR46","doi-asserted-by":"crossref","unstructured":"Fostervold A, Raffelsberger N, Hetland MAK, Bakksj\u00f8 R, Bernhoff E, Samuelsen \u00d8 et al. Risk of death in Klebsiella pneumoniae bloodstream infections is associated with specific phylogenetic lineages. J Infect. 2024.88(5).","DOI":"10.1016\/j.jinf.2024.106155"},{"key":"812_CR47","doi-asserted-by":"crossref","unstructured":"Chung KM, Liau XL, Tang SS. Bacteriophages and their host range in Multidrug-Resistant bacterial disease treatment. Pharmaceuticals. 2023.16(10).","DOI":"10.3390\/ph16101467"},{"issue":"1","key":"812_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tim.2018.08.006","volume":"27","author":"PA de Jonge","year":"2019","unstructured":"de Jonge PA, Nobrega FL, Brouns SJJ, Dutilh BE. Molecular and evolutionary determinants of bacteriophage host range. Trends Microbiol. 2019;27(1):51\u201363.","journal-title":"Trends Microbiol"},{"key":"812_CR49","doi-asserted-by":"crossref","unstructured":"Karnwal A, Jassim AY, Mohammed AA, Al-Tawaha ARMS, Selvaraj M, Malik T. Addressing the global challenge of bacterial drug resistance: insights, strategies, and future directions. Front Microbiol. 2025.16.","DOI":"10.3389\/fmicb.2025.1517772"},{"key":"812_CR50","doi-asserted-by":"crossref","unstructured":"Fujiki J, Nakamura K, Nakamura T, Iwano H. Fitness Trade-Offs between phage and antibiotic sensitivity in phage-Resistant variants: molecular action and insights into clinical applications for phage therapy. Int J Mol Sci. 2023.24(21).","DOI":"10.3390\/ijms242115628"},{"issue":"7","key":"812_CR51","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.cmi.2022.01.006","volume":"28","author":"RYK Chang","year":"2022","unstructured":"Chang RYK, Chow MYT, Wang Y, Liu C, Hong Q, Morales S, et al. The effects of different doses of inhaled bacteriophage therapy for Pseudomonas aeruginosa pulmonary infections in mice. Clin Microbiol Infect. 2022;28(7):983\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"812_CR52","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1080\/22221751.2022.2051752","volume":"11","author":"WMBS Martins","year":"2022","unstructured":"Martins WMBS, Li M, Sands K, Lenzi MH, Portal E, Mathias J, et al. Effective phage cocktail to combat the rising incidence of extensively drug-resistant Klebsiella pneumoniae sequence type 16. Emerg Microbes Infections. 2022;11(1):1015\u201323.","journal-title":"Emerg Microbes Infections"},{"key":"812_CR53","first-page":"1","volume":"2015","author":"F Cao","year":"2015","unstructured":"Cao F, Wang X, Wang L, Li Z, Che J, Wang L, et al. Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug ResistanceKlebsiella pneumoniaein mice. Biomed Res Int. 2015;2015:1\u20139.","journal-title":"Biomed Res Int"},{"issue":"10","key":"812_CR54","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1093\/jac\/dky239","volume":"73","author":"M Boisson","year":"2018","unstructured":"Boisson M, Mimoz O, Hadzic M, Marchand S, Adier C, Couet W, et al. Pharmacokinetics of intravenous and nebulized gentamicin in critically ill patients. J Antimicrob Chemother. 2018;73(10):2830\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"812_CR55","doi-asserted-by":"crossref","unstructured":"Gur D, Glinert I, Aftalion M, Vagima Y, Levy Y, Rotem S et al. Inhalational gentamicin treatment is effective against Pneumonic plague in a mouse model. Front Microbiol. 2018.9.","DOI":"10.3389\/fmicb.2018.00741"},{"key":"812_CR56","doi-asserted-by":"crossref","unstructured":"Webber MA, Cornelissen A, Ceyssens P-J, T\u2019Syen J, Van Praet H, Noben J-P et al. The T7-Related Pseudomonas Putida phage \u03c615 displays Virion-Associated biofilm degradation properties. PLoS ONE. 2011.6(4).","DOI":"10.1371\/journal.pone.0018597"},{"key":"812_CR57","doi-asserted-by":"crossref","unstructured":"Majkowska-Skrobek G, \u0141\u0105tka A, Berisio R, Maciejewska B, Squeglia F, Romano M et al. Capsule-Targeting depolymerase, derived from Klebsiella KP36 phage, as a tool for the development of Anti-Virulent strategy. Viruses. 2016.8(12).","DOI":"10.3390\/v8120324"},{"key":"812_CR58","doi-asserted-by":"crossref","unstructured":"Dunstan RA, Bamert RS, Belousoff MJ, Short FL, Barlow CK, Pickard DJ et al. Mechanistic insights into the Capsule-Targeting depolymerase from a Klebsiella pneumoniae bacteriophage. Microbiol Spectr. 2021.9(1).","DOI":"10.1128\/Spectrum.01023-21"},{"key":"812_CR59","doi-asserted-by":"crossref","unstructured":"Knecht LE, Veljkovic M, Fieseler L. Diversity and function of phage encoded depolymerases. Front Microbiol. 2020.10.","DOI":"10.3389\/fmicb.2019.02949"},{"issue":"8026","key":"812_CR60","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41586-024-07681-w","volume":"632","author":"AK Br\u00f6del","year":"2024","unstructured":"Br\u00f6del AK, Charpenay LH, Galtier M, Fuche FJ, Terrasse R, Poquet C, et al. In situ targeted base editing of bacteria in the mouse gut. Nature. 2024;632(8026):877\u201384.","journal-title":"Nature"},{"key":"812_CR61","doi-asserted-by":"crossref","unstructured":"Zhu Y, Zhang F, Huang Z. Structural insights into the inactivation of CRISPR-Cas systems by diverse anti-CRISPR proteins. BMC Biol. 2018.16(1).","DOI":"10.1186\/s12915-018-0504-9"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-025-00812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-025-00812-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-025-00812-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:39:12Z","timestamp":1757410752000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-025-00812-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["812"],"URL":"https:\/\/doi.org\/10.1186\/s12941-025-00812-9","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,20]]},"assertion":[{"value":"5 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee for Animal Experimentation of Xiangyang No. 1 People\u2019s Hospital (approval number XYYYE20240114). Clinical trial number: not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"46"}}